Copyright
©The Author(s) 2024.
World J Clin Cases. May 26, 2024; 12(15): 2542-2550
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2542
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2542
Recipient | Treatment protocols |
1 | Carrimycin + Vancocin + Levofloxacin |
2 | Carrimycin + Amphotericin B |
3 | Carrimycin + Caspofungin + Trimethoprim-sulfamethoxazole |
4 | Carrimycin + Meropenem + Linezolid + Caspofungin |
5 | Carrimycin + Ganciclovir + Moxifloxacin + Trimethoprim-sulfamethoxazole + Peramivir |
6 | Carrimycin + Caspofungin + Piperacillin sodium and tazobactam sodium + Imipenem + Trimethoprim-sulfamethoxazole |
7 | Carrimycin + Meropenem + Azithromycin + Caspofungin |
8 | Carrimycin + Moxifloxacin + Ganciclovir + Peramivir + Imipenem + Piperacillin sodium and tazobactam sodium + Tigecycline + Linezolid + Fluconazole |
9 | Carrimycin + Caspofungin + Trimethoprim-sulfamethoxazole + Imipenem + Moxifloxacin |
10 | Carrimycin + Imipenem + Ganciclovir + Voriconazole |
- Citation: Cui XQ, Zhang LW, Zhao P, Feng JJ. Efficacy and safety of carrimycin in ten patients with severe pneumonia following solid organ transplantation. World J Clin Cases 2024; 12(15): 2542-2550
- URL: https://www.wjgnet.com/2307-8960/full/v12/i15/2542.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i15.2542